ARTICLE | Skinny Label Given Heavy Weight – Amarin’s Suit for Active Inducement Dismissed
Today, a unanimous Supreme Court dismissed Amarin Pharma, Inc.’s suit against generic manufacturer and ANDA applicant Hikma Pharmaceuticals USA Inc., premised on active inducement of patent infringement by encouraging uses for indications outside the “skinny label” carve out sought by…